HAEMATE P 2400/1000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE O PERFUSION.

Product Overview

About HAEMATE P 2400/1000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE O PERFUSION.

HAEMATE P 2400/1000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE O PERFUSION is a pharmaceutical product formulated to provide a ready‑to‑use solution for intravenous or infusion therapy. The product contains a powder and a disintegrating agent that, when reconstituted with the supplied diluent, yields a sterile solution suitable for clinical administration. It is intended for use in patients who require replacement of missing clotting factors, particularly in conditions such as hemophilia A, von Willebrand disease, or other bleeding disorders where factor VIII or von Willebrand factor deficiency is present. The formulation is designed to be compatible with standard infusion protocols and to maintain stability during storage and use. The product is supplied in a sterile, single‑dose vial that is intended for use by trained healthcare professionals in a hospital or clinical setting. The reconstitution process involves adding the specified volume of diluent to the powder, followed by gentle mixing to achieve a clear, homogenous solution. The final product is then administered according to the prescribing information and under the supervision of qualified medical staff.

Key Benefits & Uses

• Provides a combined source of factor VIII and von Willebrand factor for effective clotting support.
• Designed for rapid reconstitution and immediate use in intravenous or infusion therapy.
• Suitable for patients with hemophilia A or von Willebrand disease requiring factor replacement.

Active Ingredient & Action

The active components are factor VIII and von Willebrand factor, both of which play essential roles in the coagulation cascade. Factor VIII acts as a cofactor for factor IXa, facilitating the conversion of factor X to its active form, while von Willebrand factor mediates platelet adhesion and stabilizes factor VIII in circulation. Together, they help restore normal hemostasis in patients with deficiencies of these proteins.

Important Notes

Reconstitution must be performed according to the manufacturer’s instructions, using the supplied diluent and ensuring complete dissolution of the powder. The product should be stored in a refrigerator and protected from light. Use only under the guidance of a qualified healthcare professional, and follow all local regulations regarding the handling and administration of blood‑derived products. The solution is intended for intravenous or infusion use only and should not be used for other routes of administration. Dispose of any unused product in accordance with local hazardous waste guidelines.